AJJ Medtech Holdings (SGX:584) Other Current Payables: S$2.41 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is AJJ Medtech Holdings Other Current Payables?

AJJ Medtech Holdings SGX:584 Other Current Payables is S$2.41 Mil as of Jun. 2026. The stock has 4 warning signs investors should review.

AJJ Medtech Holdings's Other Current Payables for the quarter that ended in Jun. 2026 was S$2.41 Mil.

AJJ Medtech Holdings's quarterly Other Current Payables declined from Dec. 2025 (S$3.15 Mil) to Mar. 2026 (S$2.50 Mil) and declined from Mar. 2026 (S$2.50 Mil) to Jun. 2026 (S$2.41 Mil).

AJJ Medtech Holdings's annual Other Current Payables increased from Dec. 2023 (S$0.72 Mil) to Dec. 2024 (S$1.94 Mil) and increased from Dec. 2024 (S$1.94 Mil) to Dec. 2025 (S$3.15 Mil).

AJJ Medtech Holdings Other Current Payables Related Terms

AJJ Medtech Holdings Other Current Payables Historical Data

* Premium members only.

The historical data trend for AJJ Medtech Holdings's Other Current Payables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

AJJ Medtech Holdings Other Current Payables Chart

AJJ Medtech Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Other Current Payables
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.15 0.25 0.72 1.94 3.15

AJJ Medtech Holdings Quarterly Data
Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Other Current Payables Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.12 0.44 3.15 2.50 2.41

AJJ Medtech Holdings Other Current Payables Calculation

Other Current Payables is the payables owed and expected to be paid within one year or one operating cycle that not otherwise classified. It includes dividends payable and all other current payables.

Frequently Asked Questions Learn more about Other Current Payables →
What does a Other Current Payables of S$2.41 Mil mean?
AJJ Medtech Holdings (SGX:584) has a Other Current Payables of S$2.41 Mil as of Jun. 2026. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on AJJ Medtech Holdings and its competitors.
Is AJJ Medtech Holdings' Other Current Payables too high?
AJJ Medtech Holdings' current Other Current Payables is S$2.41 Mil.
How does AJJ Medtech Holdings' Other Current Payables compare to ABT and SYK?
AJJ Medtech Holdings' Other Current Payables of S$2.41 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Payables for a Medical Devices & Instruments company?
A good Other Current Payables depends on the Medical Devices & Instruments industry context. However, Other Current Payables should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Payables mean?
A high Other Current Payables can signal that a stock is expensive relative to its fundamentals. Other Current Payables is the payables owed and expected to be paid within one year that not otherwise classified. View historical data on AJJ Medtech Holdings and its competitors. AJJ Medtech Holdings's current Other Current Payables is S$2.41 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is AJJ Medtech Holdings stock overvalued right now?
AJJ Medtech Holdings (SGX:584) has a current Other Current Payables of S$2.41 Mil. The current Other Current Payables is S$2.41 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Payables calculated?
Other Current Payables is calculated from a company's financial statements. For AJJ Medtech Holdings (SGX:584), the current Other Current Payables is S$2.41 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

AJJ Medtech Holdings Business Description

Address 8 Commonwealth Lane, No. 02-04, Grande Building, Singapore, SGP, 149555
AJJ Medtech Holdings Ltd is a healthcare technology company building an integrated platform across medical devices, digital systems, and intelligent care infrastructure in Singapore, Southeast Asia, and selected international markets. It integrates artificial intelligence, robotics, and healthcare systems to support healthcare delivery across the patient care continuum. Its portfolio includes diagnostic systems, medical and dental devices, consumables, digital and robotics-enabled healthcare solutions, and turn-key supply-chain solutions. Its segments are corporate and investment holding, healthcare products and services, and healthcare digital products, which generate maximum revenue. It operates mainly in Singapore, and its revenue is derived from the sale of medical healthcare products.